Loomis, Sayles & Company’s Glaukos GKOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.6M Buy
469,388
+48,148
+11% +$6.09M 0.08% 90
2026
Q1
$45.4M Sell
421,240
-26,565
-6% -$2.99M 0.06% 109
2025
Q4
$50.6M Buy
447,805
+376
+0.1% +$35.9K 0.06% 106
2025
Q3
$36.5M Sell
447,429
-146,183
-25% -$13.4M 0.04% 148
2025
Q2
$61.3M Sell
593,612
-46,538
-7% -$4.37M 0.08% 90
2025
Q1
$63M Sell
640,150
-13,922
-2% -$1.86M 0.09% 85
2024
Q4
$98.1M Sell
654,072
-19,679
-3% -$2.71M 0.12% 68
2024
Q3
$87.8M Buy
673,751
+119,527
+22% +$14.9M 0.12% 76
2024
Q2
$65.6M Buy
554,224
+129,500
+30% +$13.7M 0.09% 88
2024
Q1
$40M Sell
424,724
-11,533
-3% -$1.03M 0.06% 159
2023
Q4
$34.7M Buy
+436,257
New +$29.7M 0.05% 172

Other funds holding GKOS

Loomis, Sayles & Company's GKOS Position: Q2 2026 in Review

Loomis, Sayles & Company increased its Glaukos (GKOS) stake by 11% in Q2 2026, buying an estimated $6.09M and bringing the position to 469,388 shares worth $65.6M. The position accounts for 0.08% of the portfolio, ranked #90.

Loomis, Sayles & Company first reported a position in GKOS in Q4 2023 and has held it in 11 quarters since. The position peaked at $98.1M in Q4 2024. 367 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

  • Loomis, Sayles & Company held 469,388 shares of Glaukos worth $65.6M as of Q2 2026.
  • Loomis, Sayles & Company bought 48,148 Glaukos shares in Q2 2026, an estimated $6.09M.
  • Glaukos made up 0.08% of Loomis, Sayles & Company's portfolio in Q2 2026, its #90 holding.
  • Loomis, Sayles & Company first reported a position in Glaukos in Q4 2023 and has held it in 11 quarters since.
  • Loomis, Sayles & Company's Glaukos position peaked at $98.1M in Q4 2024.
  • 367 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.